von Tobias Borgers | Aug. 24, 2019 | Boehringer
Overview: Parkinson’s disease is one of the most prevalent neurodegenerative disorders, which progresses with age because of damaged dopaminergic cells in the brain. Bradykinesia, rigidity, postural instability, and tremors are the symptoms of the Parkinson’s disease....
von Tobias Borgers | Aug. 23, 2019 | Glatt
11.07.2019 Implementation of real-time and in-line feedback control for a fluid bed granulation process Abstract The application of process analytical technologies (PAT) to monitor critical quality attributes (CQAs) provides an important approach to enhance process...
von Tobias Borgers | Aug. 23, 2019 | MSD
Pressemitteilung Finale Analyse der zulassungsrelevanten Phase-III-Studie KEYNOTE-048: Verbessertes Gesamtüberleben für Patienten unter Pembrolizumab (KEYTRUDA®) in der Erstlinientherapie des rezidivierenden oder metastasierenden Plattenepithelkarzinoms der...
von Tobias Borgers | Aug. 23, 2019 | Boehringer
The Global Pancreatic Beta-Cell Protection Market report presents an overview of objectives study and definition of Pancreatic Beta-Cell Protection market. This new market research report forecasts on Pancreatic Beta-Cell Protection Market providing complete market...
von Tobias Borgers | Aug. 23, 2019 | Glaxo
Issued: London, UK ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting,...
